Fengmin Lu
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis Viruses Studies and Epidemiology
- Epidemiology top 0.5%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Hepatology 58
- Hepatocellular Carcinoma Treatment and Prognosis 25
- Hepatitis C virus research 15
- Hepatitis Viruses Studies and Epidemiology 7
- Liver Disease and Transplantation 7
- Liver physiology and pathology 7
- Epidemiology 119
- Hepatitis B Virus Studies 96
- Liver Disease Diagnosis and Treatment 20
- Co-authors
- Xiangmei Chen (96 shared papers)Hui Zhuang (31 shared papers)Jun Nie (6 shared papers)Dongzhi Yang (5 shared papers)John Alan Diehl (3 shared papers)Qiang Xu (3 shared papers)Yingshan Zhou (2 shared papers)Andrew B. Gladden (1 shared paper)
- Journals
- Journal of Hepatology (11 papers)Journal of Medical Virology (11 papers)Journal of Viral Hepatitis (9 papers)Emerging Microbes & Infections (8 papers)PLoS ONE (7 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Fengmin Lu
238 papers receiving 7.8k citations
Fengmin Lu's Hit Papers
Peers
Comparison fields: 5 of 125
- Hepatology 1k
- Epidemiology 2.7k
- Biomaterials 450
- Infectious Diseases 618
- Cancer Research 444
Countries citing papers authored by Fengmin Lu
This map shows the geographic impact of Fengmin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengmin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengmin Lu more than expected).
Fields of papers citing papers by Fengmin Lu
This network shows the impact of papers produced by Fengmin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengmin Lu. The network helps show where Fengmin Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengmin Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 248 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 490 | |
| 2 | 2007 | 425 | |
| 3 | A global scientific strategy to cure hepatitis B Hit paper breakdown → | 2019 | 406 |
| 4 | Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound Hit paper breakdown → | 2016 | 365 |
| 5 | 2017 | 219 | |
| 6 | An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. | 2003 | 211 |
| 7 | 2019 | 183 | |
| 8 | 2013 | 144 | |
| 9 | 2008 | 130 | |
| 10 | 2020 | 129 | |
| 11 | 2010 | 121 | |
| 12 | 2013 | 119 | |
| 13 | 2006 | 116 | |
| 14 | 2011 | 111 | |
| 15 | 2012 | 101 | |
| 16 | 2013 | 100 | |
| 17 | 2019 | 89 | |
| 18 | 2020 | 86 | |
| 19 | 2008 | 82 | |
| 20 | 2019 | 82 |
About Fengmin Lu
Fengmin Lu is a scholar working on Hepatology, Epidemiology, Oncology, Molecular Biology and Cancer Research, having authored 248 papers that have together received 8k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (96 papers), Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Liver Disease Diagnosis and Treatment (20 papers), Hepatitis C virus research (15 papers), Epigenetics and DNA Methylation (8 papers), Hepatitis Viruses Studies and Epidemiology (7 papers), Liver Disease and Transplantation (7 papers) and Liver physiology and pathology (7 papers). The work is most often cited by research in Hepatology (1k citations), Epidemiology (2.7k citations), Biomaterials (450 citations), Infectious Diseases (618 citations) and Cancer Research (444 citations). Fengmin Lu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xiangmei Chen, Hui Zhuang, Jun Nie, Dongzhi Yang, John Alan Diehl, Qiang Xu, Yingshan Zhou, Andrew B. Gladden, Jie Wang and Mingjie Yao. Their work appears in journals such as Journal of Hepatology, Journal of Medical Virology, Journal of Viral Hepatitis, Emerging Microbes & Infections and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.